Why clinicians should know about Mendelian randomization
Rheumatology (Oxford)
.
2021 Apr 6;60(4):1577-1579.
doi: 10.1093/rheumatology/keab007.
Authors
Sizheng Steven Zhao
1
2
,
Sarah L Mackie
3
4
,
Jie Zheng
2
5
Affiliations
1
Musculoskeletal Biology, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, UK.
2
Medical Research Council (MRC) Integrative Epidemiology Unit, School of Social and Community Medicine, University of Bristol, Bristol, UK.
3
Leeds Institute of Rheumatic and Musculoskeletal Medicine, Leeds, UK.
4
National Institute for Health Research Leeds Biomedical Research Centre, Leeds Teaching Hospitals, University of Leeds, Leeds, UK.
5
Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
PMID:
33493347
DOI:
10.1093/rheumatology/keab007
No abstract available
Publication types
Editorial
Research Support, Non-U.S. Gov't
MeSH terms
Evidence-Based Medicine*
Humans
Mendelian Randomization Analysis / methods*
Research Design*
Grants and funding
MC_UU_00011/4/MRC_/Medical Research Council/United Kingdom